A rare case of hepatitis a virus-induced acute liver failure managed by hemoadsorption CytoSorb and Biosky MG 350
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251321Keywords:
CytoSorb, Biosky MG350, Acute liver failureAbstract
Acute liver failure (ALF) is a severe and life-threatening condition characterized by rapid hepatic dysfunction, leading to multi-organ failure and a high mortality rate. It is primarily driven by a profound inflammatory response that exacerbates liver damage and affects systemic organ function. The pathophysiology of ALF involves an imbalance between pro-inflammatory and anti-inflammatory cytokines, which further impairs liver function and worsens clinical outcomes. One promising therapeutic intervention for managing ALF is hemoadsorption, an extracorporeal blood purification technique that helps mitigate hyperinflammation by removing toxic metabolites and pro-inflammatory cytokines. Recently, this approach has gained attention for its potential to improve patient outcomes in critical conditions, such as ALF. In this report, we present a rare case of hepatitis A virus-induced ALF complicated by septic shock, which was successfully managed using dual hemoadsorption techniques. The application of these methods significantly reduced inflammatory markers and improved liver and other organ function, highlighting the efficacy of hemoadsorption in managing ALF patients.
Metrics
References
Tan EX, Wang MX, Pang J, Lee GH. Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review. World J Gastroenterol. 2020;26(2):219-45. DOI: https://doi.org/10.3748/wjg.v26.i2.219
Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am. 2000;14:605. DOI: https://doi.org/10.1016/S0891-5520(05)70123-9
Centers for Disease Control and Prevention. Viral Hepatitis Surveillance: United States, 2013. US Department of Health and Human Services, Atlanta, GA. 2016. Available at: https://www.cdc.gov/hepatitis/statistics/2014surveillance/pdfs/2014HepSurveillanceRpt_Rev2016-09-26.pdf. Accessed on 15 February 2025.
Taylor RM, Davern T, Munoz S, Stephen-Huy H, Brendan MG, Anne ML, et al. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology. 2006;44(6):1589. DOI: https://doi.org/10.1002/hep.21439
Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998;338(5):286. DOI: https://doi.org/10.1056/NEJM199801293380503
Rugg C, Klose R, Hornung R, Nicole I, Mirjam B, Stefan S, et al. Hemoadsorption with CytoSorb in septic shock reduces catecholamine requirements and in-hospital mortality: a single-center retrospective ‘genetic’ matched analysis. Biomedicines. 2020;8(12):539. DOI: https://doi.org/10.3390/biomedicines8120539
Hawchar F, László I, Öveges N, Domonkos T, Zoltán O, Zsolt M. Extracorporeal cytokine adsorption in septic shock: a proof of concept randomized, controlled pilot study. J Crit Care. 2018;49:172-8. DOI: https://doi.org/10.1016/j.jcrc.2018.11.003
Brouwer WP, Duran S, Kuijper M, Ince C. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study. Crit Care. 2019;23(1):317. DOI: https://doi.org/10.1186/s13054-019-2588-1
Ocskay K, Tomescu D, Faltlhauser A, Jacob D, Friesecke S, Malbrain M, et al. Hemoadsorption in ‘liver indication-analysis of 109 patients’ data from the CytoSorb International Registry. J Clin Med. 2021;10(21):5182.
Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47(4):1401. DOI: https://doi.org/10.1002/hep.22177
Zuccari S, Damiani E, Domizi R, Claudia S, Mario DA, Andrea C, et al. Changes in cytokines, haemodynamics and microcirculation in patients with sepsis/septic shock undergoing continuous renal replacement therapy and blood purification with CytoSorb. Blood Purif. 2020;49(1-2):107-13. DOI: https://doi.org/10.1159/000502540
Ocskay K, Tomescu D, Faltlhauser A, David J, Sigrun F, Manu M, et al. Hemoadsorption in ‘liver indication’-analysis of 109 patients’ data from the CytoSorb International Registry. J Clin Med. 2021;10(21):5182. DOI: https://doi.org/10.3390/jcm10215182
Mehta Y, Mehta C, Kumar A, Joby VG, Aditi G, Saurabh N, et al. Experience with hemoadsorption (CytoSorb®) in the management of septic shock patients. World J Crit Care Med. 2020;9(1):1-12. DOI: https://doi.org/10.5492/wjccm.v9.i1.1
Tomescu D, P Mihai C, D Corina, Romina S, Simona D. Haemoadsorption by CytoSorb® in patients with acute liver failure: a case series. Int J Artif Organs. 2021;44(8):560-4. DOI: https://doi.org/10.1177/0391398820981383
Alharthy A, Faqihi F, Memish ZA, Abdullah B, Nasir N, Ahmad S, et al. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: a case-series. Artif Organs. 2021;45(5):E101-112. DOI: https://doi.org/10.1111/aor.13864
Paul R, Sathe P, Kumar S, Shiva P, Ma A, Prashant S. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb®) in patients with sepsis and septic shock. World J Crit Care Med. 2021;10(1):22-34. DOI: https://doi.org/10.5492/wjccm.v10.i1.22
Scharf C, Uwe L, Michael P, Andrea BP, Michael I, Michael Z, et al. Successful elimination of bilirubin in critically ill patients with acute liver dysfunction using a cytokine adsorber and albumin dialysis: a pilot study. Sci Rep. 2021;11(1):10190. DOI: https://doi.org/10.1038/s41598-021-89712-4
Popescu M, Corina D, Alexandra M, Mihaela RO, Mariana M, Dana T. Artificial liver support with CytoSorb and MARS in liver failure: a retrospective propensity matched analysis. J Clin Med. 2023;12(6):2258. DOI: https://doi.org/10.3390/jcm12062258
Mezger M, Eitel I, Ensminger S, Dirk P, Zhipan H, Graf T. Sequential use of hemadsorption using CytoSorb® and Biosky® filter-technology in a COVID-19 patient suffering from severe ARDS. Arch Clin Med Case Reports. 2020;4:969-77. DOI: https://doi.org/10.21203/rs.3.rs-47352/v1
Downloads
Published
How to Cite
Issue
Section
